SCHEMBL16513467

SCHEMBL16513467

CCC(=O)N1CCN(c2ccc(Nc3ncc4cccc(-c5cccc(C=CC(N)=O)c5)c4n3)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.58
FGFR2 P21802 2/20 0.53
JAK2 O60674 1/20 0.51
BRD4 O60885 1/20 0.51
SYK P43405 4/20 0.50
CDK4 P11802 3/20 0.46
CDK1 P06493 2/20 0.46
CCNB1 P14635 2/20 0.46
CCND1 P24385 2/20 0.46
CCNE1 P24864 2/20 0.46
CDK2 P24941 2/20 0.46
PTK2 Q05397 5/20 0.46
FGFR1 P11362 2/20 0.45
KDR P35968 2/20 0.45
MAPK10 P53779 2/20 0.44
JUN P05412 1/20 0.42
MAPK8 P45983 1/20 0.42
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
FES P07332 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16513769 0.93 EGFR (0.57) EGFRFGFR2JAK2BRD4SYK
SCHEMBL16514597 0.88 TTK (0.56) EGFRFGFR2JAK2BRD4SYK
SCHEMBL19096959 0.87 MAPK10 (0.55) EGFRFGFR2JAK2BRD4SYK
SCHEMBL16514973 0.85 EGFR (0.52) EGFRFGFR2JAK2BRD4PTK2
Fumaric Acid SCHEMBL16514713 0.84 FGFR2 (0.66) EGFRFGFR2JAK2BRD4SYK
SCHEMBL16514824 0.83 EGFR (0.50) EGFRFGFR2JAK2BRD4SYK
SCHEMBL16513466 0.82 EGFR (0.84) EGFRFGFR2JAK2BRD4FGFR1
SCHEMBL29847713 0.82 EGFR (0.84) EGFRFGFR2JAK2BRD4FGFR1
SCHEMBL16514411 0.81 MAPK10 (0.47) EGFRFGFR2JAK2BRD4SYK
SCHEMBL16514755 0.81 EGFR (0.47) EGFRFGFR2JAK2BRD4PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035936-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NeuPharma, Inc. (US) 2016-06-29 EP disclosed
WO-2015027222-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. (US) 2015-02-26 WO disclosed